Serum insulin and incident coronary heart disease in middle-aged British men

American Journal of Epidemiology

Volumn 144, Issue 3, 1996, Pages 224-234

  Perry, Ivan J ^a   Wannamethee, S Goya ^a   Whincup, Peter H ^a   Shaper, A Gerald ^a   Walker, Mary K ^a   Alberti, K George M M ^b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

blood glucose; coronary disease; prospective studies

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN;

ADULT; AGE; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; CORONARY RISK; GLUCOSE TOLERANCE; HEART INFARCTION; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; UNITED KINGDOM;

EID: 0029787975     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a008917     Document Type: Article

References (55)

1. Stout RW. Insulin and atheroma. 20-yr perspective. Diabetes Care 1990;13:631-54.
2. Jarrett RJ. Is insulin atherogenic? Diabetologia 1988;31:71-5.
3. Savage PJ, Saad MF. Insulin and atherosclerosis: villain, accomplice, or innocent bystander? Br Heart J 1993;69:473-5.
4. Sato Y, Shiraishi S, Oshida Y, et al. Experimental atherosclerosis-like lesions induced by hyperinsulinism in Wistar rats. Diabetes 1989;38:91-6.
5. Abbott WG, Lillioja S, Young AA, et al. Relationships between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population. Diabetes 1987;36: 897-904.
6. Zavaroni I, Bonora E, Pagliara M, et al. Risk factors for coronary heart disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 1989;320: 702-6.
7. Ducimetière P, Eschwege E, Papoz L, et al. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease in a middle-aged population. Diabetologia 1980;19:205-10.
8. Fontbonne AM, Eschwege EM. Insulin and cardiovascular disease: Paris Prospective Study. Diabetes Care 1991;14: 461-9.
9. Fontbonne A, Charles MA, Thibult N, et al. Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up. Diabetologia 1991;34:356-61.
10. Pyörälä K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 1979;2: 131-41.
11. Pyörälä K, Savolainen E, Kaukola S, et al. Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2 year follow-up of the Helsinki Policemen Study population. Acta Med Scand 1985; 701(suppl):38-52.
12. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979;2: 154-60.
13. Cullen K, Stenhouse NS, Wearne KL, et al. Multiple regression analysis of risk factor for cardiovascular disease and cancer mortality in Busselton, Western Australia - 13-year study. J Chronic Dis 1983;36:371-7.
14. Hargreaves AD, Logan RL, Elton RA, et al. Glucose tolerance, plasma insulin, HDL-cholesterol and obesity: 12-year follow-up and development of coronary heart disease in Edinburgh men. Atherosclerosis 1992;94:61-9.
15. Welin L, Eriksson H, Larsson B, et al. Hyperinsulinemia is not a major coronary risk factor in elderly men: the study of men born in 1913. Diabetologia 1992;35:766-70.
16. Yarnell JWG, Sweetnam PM, Marks V, et al. Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study. Br Heart J 1994;71:293-6.
17. Orchard TJ, Eichner J, Kuller LH, et al. Insulin as a predictor of coronary heart disease: interaction with Apo E phenotype. A report from MRFIT. Ann Epidemiol 1994;4:40-9.
18. Rewers M, Shetterly SM, Baxter J, et al. Insulin and cardio-vascular disease in Hispanics and non-Hispanic whites (NHW): the San Luis Valley Diabetes Study. (Abstract). Circulation 1992;85:865.
19. Ferrara A, Barrett-Connor EL, Edelstein SL. Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: The Rancho Bernardo Study, 1984-1991. Am J Epidemiol 1994;140:857-69.
20. Kuusisto J, Mykkänen L, Pyörälä K, et al. Hyperinsulinemic microalbuminuria: a new risk indicator for coronary heart disease. Circulation 1995;91:831-7.
21. Lichtenstein MJ, Yarnell JWG, Elwood PC, et al. Sex hormones, insulin, lipids and prevalent ischemic heart disease. Am J Epidemiol 1987;126:647-57.
22. Shaper AG, Pocock SJ, Walker M, et al. The British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. Br Med J 1981;283:179-86.
23. Shaper AG, Pocock SJ, Walker M, et al. Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epidemiol Community Health 1985; 39:197-209.
24. Shaper AG, Cook DG, Walker M, et al. Prevalence of ischaemic heart disease in middle-aged British men. Br Heart J 1984;51:595-605.
25. Shaper AG, Phillips AN, Pocock SJ, et al. Risk factors for stroke in middle-aged British men. Br Med J 1991;302: 1111-15.
26. Shaper AG, Wannamethee G. Physical activity and ischaemic heart disease in middle-aged British men. Br Heart J 1991;66: 384-94.
27. Wannamethee G, Shaper AG. Physical activity and stroke in middle-aged British men. Br Med J 1992;304:597-601.
28. Pocock SJ, Ashby D, Shaper AG, et al. Diurnal variations in serum biochemical and haematological measurements. J Clin Path 1989;42:172-9.
29. Thelle DS, Shaper AG, Whitehead TP, et al. Blood lipids in middle-aged British men. Br Heart J 1984;49:205-13.
30. Andersen L, Dinesen B, Jorgensen PN, et al. Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 1993;39:578-82.
31. Cook DG, Shaper AG, Thelle DS, et al. Serum uric acid, serum glucose and diabetes: relationships in a population study. Postgrad Med J 1986;62:1001-6.
32. Phillips AN, Shaper AG, Pocock SJ, et al. The role of risk factors in heart attack occurring in men with pre-existing IHD. Br Heart J 1988;60:404-10.
33. Walker M, Shaper AG. Follow-up of subjects in prospective studies in general practice. J R Coll Gen Pract 1984;34: 197-209.
34. Perry IJ, Wannamethee SG, Walker MK, et al. Prospective study of risk factors for development of non-insulin-dependent diabetes in middle-aged British men. Br Med J 1995;310: 560-4.
35. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34:187-220.
36. Perry IJ, Wannamethee SG, Whincup PH, et al. Asymptomatic hyperglycaemia and major IHD events in Britain. J Epidemiol Community Health 1994;48:538-42.
37. Phillips AN. Statistical issues in prospective studies of risk factors for ischaemic heart disease. PhD dissertation. London: University of London, 1986.
38. Cigolini M, Seidell JC, Charzewska J, et al. Fasting serum insulin in relation to fat distribution, serum lipid profile, and blood pressure in European women: the European Fat Distribution Study. Metabolism 1991;40:781-7.
39. Mykkänen L, Laakso M, Pyörälä K. High plasma insulin level associated with coronary heart disease in the elderly. Am J Epidemiol 1993;137:1190-1202.
40. Deprès J-P, Moorjani S, Lupien PJ, et al. Regional distribution of body fat, plasma lipoprotein and cardiovascular disease. Arteriosclerosis 1990;10:497-511.
41. Marti B, Tuomilehto J, Salomaa V, et al. Body fat distribution in the Finnish population: environmental determinants and predictive power for cardiovascular risk factor levels. J Epidemiol Community Health 1991;45:131-7.
42. Modan M, Or J, Karaski A, et al. Hyperinsulinemia, sex and risk of atherosclerotic cardiovascular disease. Circulation 1991;84:1165-75.
43. Durrington PN. Is insulin atherogenic? Diabetic Med 1992;9: 597-600.
44. Ingelfinger JA, Bennett PH, Liebow IM, et al. Coronary heart disease in the Pima Indians: electrocardiographic findings and post-mortem evidence of myocardial infarction in a population with a high prevalence of diabetes mellitus. Diabetes 1976; 25:561-5.
45. McKeigue P, Davey G. Association between insulin levels and cardiovascular disease are confounded by comorbidity. Diabetes Care 1995;18:1294-8.
46. Smith GD, Phillips A. Declaring independence: why we should be cautious. J Epidemiol Community Health 1990;44: 257-8.
47. The University Group Diabetes Program. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. Diabetes 1982;31(suppl 5):1-77.
48. Wingard DL, Barrett-Connor EL, Ferrara A. Is insulin really a heart disease risk factor? Diabetes Care 1995;18:1299-1304.
49. Jarrett RJ, Shipley MJ. Type 2 (non-insulin-dependent diabetes and cardiovascular disease - putative association via common antecedents; further evidence from the Whitehall study. Diabetologia 1988;31:737-40.
50. Hales CN, Barker DJP, Clark PMS, et al. Fetal and infant growth and impaired glucose tolerance at age 64. Br Med J 1991;303:1019-22.
51. Warram JH, Martin BC, Krolewski AS, et al. Slow glucose removal rate and hyperinsulinemia precede the development of type 2 diabetes in the offspring of diabetic parents. Ann Intern Med 1990;113:909-15.
52. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1606.
53. Haffner SM, Stern MP, Hazuda HP, et al. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990;263:2893-8.
54. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as a predictor of vascular disease in non-diabetic subjects. Lancet 1988;2:530-3.
55. Mykkänen L, Haffner SM, Kuusisto J, et al. Microalbuminuria precedes the development of NIDDM. Diabetes 1994;43: 552-7.